Does Victoza Affect Menstrual Cycle? UK Medical Guide

Does Victoza affect menstrual cycle? Victoza (liraglutide) is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes treatment. Whilst menstrual cycle disturbances are not listed as recognised adverse effects in the MHRA-approved Summary of Product Characteristics, some women report period changes after starting this medication. There is no established direct pharmacological link between Victoza and menstrual alterations in clinical trials. However, indirect mechanisms—including weight loss, improved insulin sensitivity, and metabolic changes—may influence menstrual regularity through effects on hormonal balance and the hypothalamic-pituitary-ovarian axis, particularly in women with polycystic ovary syndrome or obesity.

Does Victoza Affect Menstrual Cycle?

Victoza (liraglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus. For weight management, liraglutide is marketed as Saxenda at a higher dose (3mg), not as Victoza. Whilst menstrual cycle disturbances are not listed as a recognised adverse effect in the Summary of Product Characteristics (SmPC) approved by the Medicines and Healthcare products Regulatory Agency (MHRA), some patients have anecdotally reported changes to their periods after starting this medication.

There is no official, direct pharmacological link established between Victoza and menstrual cycle alterations in clinical trials or pharmacovigilance data. However, several indirect mechanisms may contribute to period changes in women taking liraglutide. The medication's actions—enhancing insulin secretion, suppressing glucagon secretion, slowing gastric emptying, and reducing appetite—can lead to significant weight loss, particularly in those with obesity. Weight changes, whether loss or gain, are well-recognised factors that can influence menstrual regularity through effects on oestrogen metabolism and hypothalamic-pituitary-ovarian axis function.

Additionally, improved glycaemic control itself may affect hormonal balance in women with type 2 diabetes, particularly those with polycystic ovary syndrome (PCOS), a condition frequently associated with insulin resistance. As metabolic parameters improve, some women may experience changes in cycle regularity, ovulation patterns, or menstrual flow. It is important to distinguish between medication effects, disease-related factors, and the physiological consequences of weight loss when evaluating menstrual changes in women prescribed Victoza.

It should be noted that liraglutide is not recommended during pregnancy or breastfeeding, and effective contraception is advised for women of childbearing potential while taking this medication.

Mounjaro®

Average 22.5% body weight loss

Mounjaro® is the most innovative GLP-1 medication proven to dramatically curb appetite, hunger, and cravings to help professional men achieve substantial weight loss.

Start Here

Wegovy®

Average 16.9% body weight loss

Wegovy® is a weekly injectable GLP-1 medication with proven effectiveness in reducing appetite, hunger, and cravings to help busy professionals lose significant weight.

Start Here

Find out if you’re eligible

Reported Menstrual Changes in Women Taking Victoza

Some women taking Victoza have reported menstrual changes, though these are not formally documented as adverse reactions in clinical trials or the MHRA-approved SmPC. Anecdotally reported changes include:

• Irregular cycles – some women notice their periods become less predictable in timing

• Heavier or lighter bleeding – alterations in menstrual flow volume

• Missed periods (amenorrhoea) – particularly in those experiencing significant weight loss

• Changes in premenstrual symptoms – variations in mood, bloating, or breast tenderness

• Breakthrough bleeding – spotting between expected menstrual periods

The potential mechanism behind these changes is likely multifactorial. Weight loss, which can occur with GLP-1 receptor agonists, may disrupt the hypothalamic-pituitary-ovarian axis. Adipose tissue plays a crucial role in oestrogen production and metabolism; significant fat loss can temporarily alter hormonal balance until a new equilibrium is established. In women with PCOS and insulin resistance, improved insulin sensitivity may restore ovulation, leading to more regular—or initially more erratic—menstrual patterns.

Gastrointestinal side effects of Victoza, including nausea and reduced appetite, may also contribute indirectly through nutritional changes that can affect reproductive hormone production. The stress of adapting to a new medication regimen, combined with lifestyle modifications often undertaken alongside diabetes treatment, might also influence menstrual regularity, though this connection is speculative.

It is essential to note that correlation does not imply causation. Many factors can affect menstrual cycles, and temporal association with starting Victoza does not definitively establish the medication as the cause.

Importantly, women should be aware that improved metabolic health and weight loss may increase fertility, particularly in those with PCOS. Effective contraception is advised for women taking liraglutide who do not wish to become pregnant, as the medication should be discontinued if pregnancy occurs.

When to Speak to Your GP About Period Changes

Whilst some menstrual variation may be expected when starting Victoza, particularly if accompanied by weight loss, certain changes warrant prompt medical evaluation. You should contact your GP or healthcare provider if you experience:

• Absent periods for three months or more (amenorrhoea), especially if you are not menopausal and pregnancy has been excluded

• Very heavy bleeding requiring pad or tampon changes every hour, or passing large clots

• Bleeding lasting longer than seven days or bleeding between periods

• Severe pelvic pain accompanying menstrual changes

• Unexpected pregnancy symptoms, as improved fertility may occur with weight loss and metabolic improvement

• Postmenopausal bleeding – any vaginal bleeding after 12 months without periods requires urgent investigation via a 2-week wait referral pathway, as per NICE guideline NG12

Your GP will take a thorough history, including the timing of menstrual changes relative to starting Victoza, degree of weight loss, and any other symptoms. Initial assessment typically includes pregnancy testing (as fertility may improve with weight loss), full blood count and ferritin (to check for anaemia if bleeding is heavy), thyroid function tests, and consideration of other causes such as PCOS, premature ovarian insufficiency, or structural abnormalities.

According to NICE guidance NG88, persistent menstrual irregularities require investigation to exclude underlying pathology. Your doctor may perform a pelvic examination, arrange ultrasound imaging, or check hormone levels including follicle-stimulating hormone (FSH), luteinising hormone (LH), and prolactin. In some cases, STI testing may be appropriate, particularly if there is postcoital bleeding.

If you suspect you may be pregnant while taking Victoza, contact your healthcare provider immediately as liraglutide is not recommended during pregnancy. If menstrual changes are significantly affecting your quality of life or causing concern, do not hesitate to seek medical advice. Your healthcare team can help determine whether changes are related to Victoza, weight loss, improved metabolic health, or require further investigation for alternative causes.

Managing Menstrual Symptoms While on Victoza

If you experience menstrual changes whilst taking Victoza, several strategies may help manage symptoms whilst continuing treatment. Practical management approaches include:

Monitoring and documentation: Keep a menstrual diary recording cycle length, flow heaviness, and associated symptoms. This information is valuable for your healthcare provider in determining patterns and whether intervention is needed. Smartphone applications can facilitate tracking and identify trends over time.

Nutritional support: Ensure adequate caloric intake despite appetite suppression. Rapid or excessive weight loss can exacerbate menstrual irregularities. General advice suggests gradual, sustainable weight reduction of 0.5–1 kg per week, though this should be individualised with your healthcare team. Maintain sufficient intake of iron-rich foods, particularly if experiencing heavier periods. If you develop symptoms of anaemia such as fatigue or pallor, your GP may check your full blood count and ferritin levels before considering iron supplementation.

Lifestyle modifications: Regular physical activity, stress management techniques, and adequate sleep support hormonal balance. However, avoid excessive exercise, which can further disrupt menstrual function, particularly in the context of caloric restriction.

Symptomatic relief: For menstrual pain, paracetamol or ibuprofen (if not contraindicated) may provide relief. Ibuprofen should be used with caution in those with kidney disease, gastrointestinal conditions, or certain cardiovascular risks. Heavy bleeding may respond to tranexamic acid, which your GP can prescribe if appropriate and if you have no history of thromboembolic disease. Hormonal contraception can regulate cycles and reduce heavy bleeding, though discuss this option with your healthcare provider to ensure compatibility with your diabetes management plan.

Contraception advice: If you do not wish to become pregnant, effective contraception is advised while taking liraglutide, as the medication is not recommended during pregnancy. If you are planning pregnancy, discuss this with your healthcare provider as you will need to stop liraglutide before conception.

Patience and reassessment: Menstrual changes often settle within 3–6 months as your body adjusts to weight loss and metabolic improvements. However, if symptoms persist, worsen, or significantly impact quality of life, discuss with your GP whether continuing Victoza remains appropriate or whether alternative diabetes treatments should be considered. Never discontinue prescribed medication without medical guidance, as this may compromise glycaemic control and increase diabetes-related complications.

If you suspect your menstrual changes might be a side effect of Victoza, you can report this through the MHRA Yellow Card Scheme, which helps monitor medication safety.

Frequently Asked Questions